Literature DB >> 8272401

Microdialysis calibration using retrodialysis and zero-net flux: application to a study of the distribution of zidovudine to rabbit cerebrospinal fluid and thalamus.

Y Wang1, S L Wong, R J Sawchuk.   

Abstract

A retrodialysis (RD) method for the real-time calibration of on-line microdialysis (MD) procedures was investigated in vitro and in vivo. Calibration by retrodialysis was simultaneously validated through the use of a zero-net flux (ZNF) method, which assumes directional independence of diffusion of the solute. In RD, a calibrator with dialysance (PeA; effective permeability-surface area product) similar to that of the compound of interest is introduced into the perfusate. If the calibrator is suitable, its loss from the perfusate during RD is identical to the recovery of the solute of interest determined simultaneously by normal MD. Two antiviral nucleosides (AZT and AZdU) which differ structurally by only a methylene group were utilized as solute and calibrator, respectively. Both nucleosides exhibited similar recovery and loss at flow rates of 0.5 to 5 microL/min in vitro, indicating a similar PeA product in this flow domain. Furthermore, both compounds showed similar loss into the lateral ventricle or thalamus of rabbits (n = 4) during RD at a flow rate of 1 microL/min for 6 hr. The relative loss decreased rapidly within the first hour, reaching a relatively stable value after 2 hr. The significant reduction in the loss of AZdU and AZT in vivo compared with that in vitro likely results from a lower diffusion coefficient in tissue. The distribution of AZT between plasma and cerebrospinal fluid (CSF) in the ventricle and extracellular fluid (ECF) in thalamus was determined at steady state using calibration by RD and ZNF simultaneously.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8272401     DOI: 10.1023/a:1018906821725

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  13 in total

1.  Quantitative microdialysis: analysis of transients and application to pharmacokinetics in brain.

Authors:  P F Morrison; P M Bungay; J K Hsiao; B A Ball; I N Mefford; R L Dedrick
Journal:  J Neurochem       Date:  1991-07       Impact factor: 5.372

2.  In vivo microdialysis sampling for pharmacokinetic investigations.

Authors:  D O Scott; L R Sorenson; K L Steele; D L Puckett; C E Lunte
Journal:  Pharm Res       Date:  1991-03       Impact factor: 4.200

3.  A microdialysis method allowing characterization of intercellular water space in humans.

Authors:  P Lönnroth; P A Jansson; U Smith
Journal:  Am J Physiol       Date:  1987-08

4.  Functional correlates of dopamine neurotransmission.

Authors:  U Ungerstedt; C Pycock
Journal:  Bull Schweiz Akad Med Wiss       Date:  1974-07

5.  Mass transfer in brain dialysis devices--a new method for the estimation of extracellular amino acids concentration.

Authors:  I Jacobson; M Sandberg; A Hamberger
Journal:  J Neurosci Methods       Date:  1985 Nov-Dec       Impact factor: 2.390

6.  The concentrations of free amino acids and other electrolytes in cerebrospinal fluid, in vivo dialysate of brain, and blood plasma of the dog.

Authors:  L Bito; H Davson; E Levin; M Murray; N Snider
Journal:  J Neurochem       Date:  1966-11       Impact factor: 5.372

7.  Theophylline concentration in the extracellular space of the rat brain: measurement by microdialysis and relation to behaviour.

Authors:  L Ståhle; S Segersvärd; U Ungerstedt
Journal:  Eur J Pharmacol       Date:  1990-08-28       Impact factor: 4.432

8.  Analysis of zidovudine distribution to specific regions in rabbit brain using microdialysis.

Authors:  S L Wong; Y Wang; R J Sawchuk
Journal:  Pharm Res       Date:  1992-03       Impact factor: 4.200

9.  Steady-state theory for quantitative microdialysis of solutes and water in vivo and in vitro.

Authors:  P M Bungay; P F Morrison; R L Dedrick
Journal:  Life Sci       Date:  1990       Impact factor: 5.037

10.  Antipyrine as a dialyzable reference to correct differences in efficiency among and within sampling devices during in vivo microdialysis.

Authors:  R A Yokel; D D Allen; D E Burgio; P J McNamara
Journal:  J Pharmacol Toxicol Methods       Date:  1992-05       Impact factor: 1.950

View more
  45 in total

Review 1.  Issues in pharmacokinetics and pharmacodynamics of anti-infective agents: distribution in tissue.

Authors:  Markus Müller; Amparo dela Peña; Hartmut Derendorf
Journal:  Antimicrob Agents Chemother       Date:  2004-05       Impact factor: 5.191

2.  The impact of bevacizumab on temozolomide concentrations in intracranial U87 gliomas.

Authors:  Rachel Grossman; Michelle A Rudek; Harry Brastianos; Patti Zadnik; Henry Brem; Betty Tyler; Jaishri O Blakeley
Journal:  Cancer Chemother Pharmacol       Date:  2012-05-27       Impact factor: 3.333

3.  An integrated model for the analysis of pharmacokinetic data from microdialysis experiments.

Authors:  Karin Tunblad; Margareta Hammarlund-Udenaes; E Niclas Jonsson
Journal:  Pharm Res       Date:  2004-09       Impact factor: 4.200

4.  The chinchilla microdialysis model for the study of antibiotic distribution to middle ear fluid.

Authors:  Belinda W Y Cheung; Wei Liu; Ping Ji; Linda L Cartier; Zhihong Li; Nael Mostafa; Ronald J Sawchuk
Journal:  AAPS J       Date:  2006-02-03       Impact factor: 4.009

5.  Development of tissue-targeted metabonomics. Part 1. Analytical considerations.

Authors:  Kristin E Price; Craig E Lunte; Cynthia K Larive
Journal:  J Pharm Biomed Anal       Date:  2007-11-29       Impact factor: 3.935

6.  Model for concomitant microdialysis sampling of the pons and cerebral cortex in rhesus macaques (Macaca mulatta).

Authors:  Cynthia M McCully; Devang Pastakia; John Bacher; Marvin L Thomas; Emilie A Steffen-Smith; Kadharbatcha Saleem; Robert F Murphy; Stuart Walbridge; Lauren Brinster; Brigitte C Widemann; Katherine E Warren
Journal:  Comp Med       Date:  2013-08       Impact factor: 0.982

7.  Using microdialysis to analyse the passage of monovalent nanobodies through the blood-brain barrier.

Authors:  G Caljon; V Caveliers; T Lahoutte; B Stijlemans; G H Ghassabeh; J Van Den Abbeele; I Smolders; P De Baetselier; Y Michotte; S Muyldermans; S Magez; R Clinckers
Journal:  Br J Pharmacol       Date:  2012-04       Impact factor: 8.739

8.  A neuropharmacokinetic assessment of bafetinib, a second generation dual BCR-Abl/Lyn tyrosine kinase inhibitor, in patients with recurrent high-grade gliomas.

Authors:  Jana Portnow; Behnam Badie; Susan Markel; An Liu; Massimo D'Apuzzo; Paul Frankel; Rahul Jandial; Timothy W Synold
Journal:  Eur J Cancer       Date:  2013-02-04       Impact factor: 9.162

9.  Dermal pharmacokinetics of microemulsion formulations determined by in vivo microdialysis.

Authors:  M Kreilgaard
Journal:  Pharm Res       Date:  2001-03       Impact factor: 4.200

10.  Development of a dog microdialysis model for determining synovial fluid pharmacokinetics of anti-arthritis compounds exemplified by methotrexate.

Authors:  Mingxin Qian; Wanda West; Jing-Tao Wu; Bing Lu; David D Christ
Journal:  Pharm Res       Date:  2003-04       Impact factor: 4.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.